U.S. FDA Grants Temporary Importation of TEGLUTIK (Riluzole 5 mg/mL Oral Suspension) into the United States
The U.S. Food and Drug Administration (FDA) recently granted temporary importation of TEGLUTIK (riluzole 5 mg/mL oral suspension) into the United States. To mitigate the critical and ongoing shortage of FDA-approved Tiglutik (riluzole oral suspension, 50 mg/10 mL) in the United States, the FDA recently permitted temporary importation of TEGLUTIK from the United Kingdom. Marketed … Read more
U.S. FDA Grants Temporary Importation of TEGLUTIK (Riluzole 5 mg/mL Oral Suspension) into the United States from Spain
The U.S. Food and Drug Administration (FDA) recently granted temporary importation of TEGLUTIK (riluzole 5 mg/mL oral suspension) into the United States. To mitigate the critical and ongoing shortage of FDA-approved Tiglutik (riluzole oral suspension, 50 mg/10 mL) in the United States, the FDA recently permitted temporary importation of TEGLUTIK from Spain. TEGLUTIK is both … Read more
U.S. FDA Grants Temporary Importation of TEGLUTIK (Riluzole 5 mg/mL Oral Suspension) into the United States from Greece
The U.S. Food and Drug Administration (FDA) recently granted temporary importation of TEGLUTIK (riluzole 5 mg/mL oral suspension) into the United States. To mitigate the critical and ongoing shortage of FDA-approved Tiglutik (riluzole oral suspension, 50 mg/10 mL) in the United States, the FDA recently permitted temporary importation of TEGLUTIK from Greece. Marketed by Italfarmaco … Read more